Elham Roshandel

560 total citations
60 papers, 376 citations indexed

About

Elham Roshandel is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Elham Roshandel has authored 60 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 18 papers in Oncology and 18 papers in Immunology. Recurrent topics in Elham Roshandel's work include Hematopoietic Stem Cell Transplantation (23 papers), Immune Cell Function and Interaction (10 papers) and CAR-T cell therapy research (8 papers). Elham Roshandel is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Immune Cell Function and Interaction (10 papers) and CAR-T cell therapy research (8 papers). Elham Roshandel collaborates with scholars based in Iran, Canada and Sweden. Elham Roshandel's co-authors include Abbas Hajifathali, Mahshid Mehdizadeh, Mohammad Hossein Kazemi, Maryam Salimi, Mozhdeh Mohammadian, Behrouz Farhadihosseinabadi, Rouzbeh Chegeni, Maryam Ghasemi, Karim Shamsasenjan and Arezou Sayad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Biomedicine & Pharmacotherapy.

In The Last Decade

Elham Roshandel

51 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Roshandel Iran 11 126 101 100 93 53 60 376
Anahita Mojiri United States 12 178 1.4× 44 0.4× 80 0.8× 53 0.6× 33 0.6× 25 449
Martina Serra Italy 8 112 0.9× 100 1.0× 36 0.4× 156 1.7× 121 2.3× 16 408
Kazuhiro Mochizuki Japan 15 179 1.4× 153 1.5× 198 2.0× 286 3.1× 41 0.8× 47 640
Fani Kalala Greece 9 77 0.6× 91 0.9× 26 0.3× 182 2.0× 36 0.7× 28 355
Jaime Morales‐Arias United States 7 52 0.4× 85 0.8× 149 1.5× 94 1.0× 45 0.8× 8 337
Qiangguo Gao China 11 139 1.1× 121 1.2× 68 0.7× 194 2.1× 41 0.8× 23 419
Hayato Maruoka Japan 10 54 0.4× 73 0.7× 65 0.7× 103 1.1× 56 1.1× 35 312
Maria Antonella Laginestra Italy 12 147 1.2× 144 1.4× 37 0.4× 82 0.9× 56 1.1× 25 382
Toni Valković Croatia 13 194 1.5× 335 3.3× 110 1.1× 214 2.3× 60 1.1× 42 586
Ioanna Ε. Stergiou Greece 12 158 1.3× 52 0.5× 34 0.3× 47 0.5× 20 0.4× 41 358

Countries citing papers authored by Elham Roshandel

Since Specialization
Citations

This map shows the geographic impact of Elham Roshandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Roshandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Roshandel more than expected).

Fields of papers citing papers by Elham Roshandel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Roshandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Roshandel. The network helps show where Elham Roshandel may publish in the future.

Co-authorship network of co-authors of Elham Roshandel

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Roshandel. A scholar is included among the top collaborators of Elham Roshandel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Roshandel. Elham Roshandel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehravar, Maryam, et al.. (2025). Mechanism of Wound Healing by Hematopoietic Stem Cells. 12(2).
3.
Mehravar, Maryam, et al.. (2025). Utilization of MSC-Derived Extracellular Vesicles and Bioscaffolds in Enhancing Oocyte In Vitro Maturation and Culture: A Review. Reproductive Sciences. 32(9). 2829–2841. 1 indexed citations
4.
Roshandel, Elham, et al.. (2024). Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective. Biomarker Research. 12(1). 66–66. 3 indexed citations
5.
Ghasemi, Maryam, Elham Roshandel, Mozhdeh Mohammadian, et al.. (2023). Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials. Stem Cell Research & Therapy. 14(1). 122–122. 28 indexed citations
8.
Mirfakhraie, Reza, et al.. (2023). Mesenchymal stem cell transplantation for infertility treatment: A review. Biomedical Research and Therapy. 10(6). 5744–5756. 4 indexed citations
9.
Ringdén, Olle, Elham Roshandel, Mohammad Mahdi Majidi, et al.. (2022). Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells. Transplantation and Cellular Therapy. 28(3). S222–S222. 1 indexed citations
10.
Roshandel, Elham, et al.. (2022). Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors. Health Science Reports. 5(2). e536–e536. 8 indexed citations
11.
Soleimani, Masoud, et al.. (2022). Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID‐19 infection: A case report. SHILAP Revista de lepidopterología. 10(5). e05851–e05851. 2 indexed citations
12.
Roshandel, Elham, et al.. (2022). Cell-Based Therapy Approaches in Treatment of Non-obstructive Azoospermia. Reproductive Sciences. 30(5). 1482–1494. 6 indexed citations
13.
Kazemi, Mohammad Hossein, et al.. (2021). Oncolytic Viruses: A Promising Solution for Relapse Prevention after Autologous Hematopoietic Stem Cell Transplantation. SHILAP Revista de lepidopterología. 31(198). 194–212. 2 indexed citations
14.
Roshandel, Elham, Maryam Salimi, Sina Salari, et al.. (2021). Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients. Transfusion and Apheresis Science. 60(4). 103141–103141. 7 indexed citations
15.
Kazemi, Mohammad Hossein, Elham Roshandel, Mahshid Mehdizadeh, et al.. (2021). Oncolytic virotherapy in hematopoietic stem cell transplantation. Human Immunology. 82(9). 640–648. 9 indexed citations
16.
Hajifathali, Abbas, et al.. (2020). The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival. Transfusion and Apheresis Science. 60(2). 103009–103009. 6 indexed citations
17.
Roshandel, Elham, et al.. (2020). Pre-transplant thrombocytopenia predicts engraftment time and blood products requirement in allogeneic hematopoietic stem cell transplantation patients. Transfusion and Apheresis Science. 59(4). 102810–102810. 5 indexed citations
18.
Asadi, Farkhondeh, et al.. (2019). Machine Learning Classification Algorithms to Predict aGvHD following Allo-HSCT: A Systematic Review. Methods of Information in Medicine. 58(6). 205–212. 8 indexed citations
19.
Chegeni, Rouzbeh, et al.. (2019). Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation. Transfusion and Apheresis Science. 59(2). 102696–102696. 11 indexed citations
20.
Roshandel, Elham, et al.. (2018). The effect of circadian rhythm on the secretion of adrenaline and noradrenaline and its relationship with mobilization of CD34 stem cells. Research in Medicine. 42(1). 1–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026